Solasto Past Earnings Performance
Past criteria checks 0/6
Solasto's earnings have been declining at an average annual rate of -12.6%, while the Healthcare industry saw earnings growing at 6.4% annually. Revenues have been growing at an average rate of 8.7% per year. Solasto's return on equity is 1.4%, and it has net margins of 0.2%.
Key information
-12.6%
Earnings growth rate
-12.7%
EPS growth rate
| Healthcare Industry Growth | 7.9% |
| Revenue growth rate | 8.7% |
| Return on equity | 1.4% |
| Net Margin | 0.2% |
| Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
Investors Can Find Comfort In Solasto's (TSE:6197) Earnings Quality
Nov 19
There May Be Reason For Hope In Solasto's (TSE:6197) Disappointing Earnings
May 21Recent updates
Investors Can Find Comfort In Solasto's (TSE:6197) Earnings Quality
Nov 19Here's What Analysts Are Forecasting For Solasto Corporation (TSE:6197) After Its Interim Results
Nov 14Why Investors Shouldn't Be Surprised By Solasto Corporation's (TSE:6197) 29% Share Price Surge
Sep 04Solasto (TSE:6197) Will Pay A Dividend Of ¥10.00
Aug 13There May Be Reason For Hope In Solasto's (TSE:6197) Disappointing Earnings
May 21Revenue & Expenses Breakdown
How Solasto makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 136,544 | 302 | 13,901 | 0 |
| 30 Jun 24 | 136,317 | -280 | 16,168 | 0 |
| 31 Mar 24 | 135,139 | 2,257 | 14,593 | 0 |
| 31 Dec 23 | 133,686 | 4,903 | 14,618 | 0 |
| 30 Sep 23 | 132,931 | 5,210 | 14,418 | 0 |
| 30 Jun 23 | 131,952 | 5,654 | 13,984 | 0 |
| 31 Mar 23 | 131,088 | 3,172 | 13,693 | 0 |
| 31 Dec 22 | 128,424 | 2,967 | 13,889 | 0 |
| 30 Sep 22 | 124,229 | 3,220 | 13,522 | 0 |
| 30 Jun 22 | 120,203 | 3,340 | 13,265 | 0 |
| 31 Mar 22 | 117,239 | 3,502 | 12,744 | 0 |
| 31 Dec 21 | 115,319 | 3,940 | 12,505 | 0 |
| 30 Sep 21 | 113,972 | 3,890 | 12,284 | 0 |
| 30 Jun 21 | 110,317 | 3,986 | 11,748 | 0 |
| 31 Mar 21 | 106,182 | 3,538 | 11,512 | 0 |
| 31 Dec 20 | 102,410 | 3,586 | 12,184 | 0 |
| 30 Sep 20 | 99,018 | 3,486 | 11,802 | 0 |
| 30 Jun 20 | 97,342 | 3,227 | 11,642 | 0 |
| 31 Mar 20 | 95,719 | 4,739 | 11,535 | 0 |
| 31 Dec 19 | 93,430 | 4,916 | 11,426 | 0 |
| 30 Sep 19 | 90,281 | 4,905 | 11,148 | 0 |
| 30 Jun 19 | 87,109 | 4,823 | 10,797 | 0 |
| 31 Mar 19 | 84,251 | 3,506 | 10,126 | 0 |
| 31 Dec 18 | 82,232 | 3,363 | 9,789 | 0 |
| 30 Sep 18 | 80,097 | 3,083 | 9,493 | 0 |
| 30 Jun 18 | 77,381 | 2,914 | 9,130 | 0 |
| 31 Mar 18 | 74,329 | 2,710 | 8,792 | 0 |
| 31 Dec 17 | 71,067 | 2,649 | 8,451 | 0 |
| 30 Sep 17 | 68,430 | 2,625 | 7,997 | 0 |
| 30 Jun 17 | 66,797 | 2,582 | 7,667 | 0 |
| 31 Mar 17 | 65,413 | 2,473 | 7,512 | 0 |
| 31 Dec 16 | 64,560 | 2,211 | 7,312 | 0 |
| 31 Mar 16 | 63,070 | 1,993 | 7,292 | 0 |
| 31 Mar 15 | 60,181 | 1,451 | 7,015 | 0 |
| 31 Mar 14 | 58,423 | 2,394 | 7,255 | 0 |
Quality Earnings: 6197 has a large one-off loss of ¥3.9B impacting its last 12 months of financial results to 30th September, 2024.
Growing Profit Margin: 6197's current net profit margins (0.2%) are lower than last year (3.9%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 6197's earnings have declined by 12.6% per year over the past 5 years.
Accelerating Growth: 6197's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: 6197 had negative earnings growth (-94.2%) over the past year, making it difficult to compare to the Healthcare industry average (10.6%).
Return on Equity
High ROE: 6197's Return on Equity (1.4%) is considered low.